153 related articles for article (PubMed ID: 37794367)
1. Panretinal photocoagulation plus intravitreal conbercept for diabetic retinopathy in real world: a retrospective study.
Wang X; Yao J; Li S; Zhang W; Wang L; Zhou A
BMC Ophthalmol; 2023 Oct; 23(1):400. PubMed ID: 37794367
[TBL] [Abstract][Full Text] [Related]
2. A comparison between the therapeutic effects of Conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy.
Sun Y; Qi H
Front Endocrinol (Lausanne); 2022; 13():1038757. PubMed ID: 36714571
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Real-World Outcomes of Corneal Changes in Proliferative Diabetic Retinopathy: Panretinal Photocoagulation vs. Intravitreal Conbercept.
Li Z; Zhou L; Huang C; Lu T; Liang J; Cong Q; Lan Y; Jin C
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103765. PubMed ID: 37625766
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal neovascular changes on optical coherence tomography angiography in proliferative diabetic retinopathy treated with panretinal photocoagulation alone versus with intravitreal conbercept plus panretinal photocoagulation: a pilot study.
He F; Yu W
Eye (Lond); 2020 Aug; 34(8):1413-1418. PubMed ID: 31719675
[TBL] [Abstract][Full Text] [Related]
5. Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study.
Zhang W; Zhao G; Fan W; Zhao T
BMC Ophthalmol; 2021 Apr; 21(1):160. PubMed ID: 33789617
[TBL] [Abstract][Full Text] [Related]
6. Single-Dose Intravitreal Conbercept before Panretinal Photocoagulation as an Effective Adjunctive Treatment in Chinese Proliferative Diabetic Retinopathy.
Zhang Q; Zhang T; Zhuang H; Sun Z; Qin Y
Ophthalmologica; 2019; 242(2):59-68. PubMed ID: 30699427
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.
Brown DM; Wykoff CC; Boyer D; Heier JS; Clark WL; Emanuelli A; Higgins PM; Singer M; Weinreich DM; Yancopoulos GD; Berliner AJ; Chu K; Reed K; Cheng Y; Vitti R
JAMA Ophthalmol; 2021 Sep; 139(9):946-955. PubMed ID: 34351414
[TBL] [Abstract][Full Text] [Related]
8. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
[TBL] [Abstract][Full Text] [Related]
9. Ultra-Response to Ranibizumab: Improvement by 4 or More Steps in Diabetic Retinopathy Severity in Diabetic Retinopathy Clinical Research Network Protocol S.
Chiang A; Garg SJ; Klufas MA; Ho AC; Hill L; Tsuboi M; Stoilov I
Ophthalmol Retina; 2021 Mar; 5(3):251-260. PubMed ID: 32735903
[TBL] [Abstract][Full Text] [Related]
10. ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alone for the treatment of proliferative diabetic retinopathy.
Barroso RMP; Messias K; Garcia DM; Cardillo JA; Scott IU; Messias A; Jorge R
Arq Bras Oftalmol; 2020; 83(6):526-534. PubMed ID: 33470281
[TBL] [Abstract][Full Text] [Related]
11. Retinal vein changes in patients with high-risk proliferative diabetic retinopathy treated with conbercept and panretinal photocoagulation co-therapy: a cohort study.
Si M; Tao Y; Zhang Z; Zhao H; Cui W; Yang M; Wang H
Front Endocrinol (Lausanne); 2023; 14():1218442. PubMed ID: 37693359
[TBL] [Abstract][Full Text] [Related]
12. Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy.
Azad AD; Chen EM; Hinkle J; Rayess N; Wu D; Eliott D; Mruthyunjaya P; Parikh R
Ophthalmol Retina; 2021 Feb; 5(2):151-159. PubMed ID: 32693033
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Quantitative Ultrawidefield Angiographic Features in Diabetic Retinopathy Treated with Aflibercept from the Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement Trial.
Kalra G; Wykoff C; Martin A; Srivastava SK; Reese J; Ehlers JP
Ophthalmol Retina; 2024 Feb; 8(2):116-125. PubMed ID: 37696393
[TBL] [Abstract][Full Text] [Related]
14. Sequence effect in the treatment of proliferative diabetic retinopathy with intravitreal ranibizumab and panretinal photocoagulation.
Cao G; Xu X; Wang C; Zhang S
Eur J Ophthalmol; 2020 Jan; 30(1):34-39. PubMed ID: 30539668
[TBL] [Abstract][Full Text] [Related]
15. Real-Time Photographic- and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes.
Yu HJ; Ehlers JP; Sevgi DD; Hach J; O'Connell M; Reese JL; Srivastava SK; Wykoff CC
Am J Ophthalmol; 2021 Jun; 226():126-136. PubMed ID: 33529593
[TBL] [Abstract][Full Text] [Related]
16. Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Melia M; Chen E; Pavlica MR; Jampol LM;
Ophthalmology; 2018 Nov; 125(11):1776-1783. PubMed ID: 29980333
[TBL] [Abstract][Full Text] [Related]
17. Long-term real-world outcomes of retinal microvasculature changes in proliferative diabetic retinopathy treated with panretinal photocoagulation vs. intravitreal conbercept.
Li Z; Zhou L; Huang C; Lu T; Liang J; Cong Q; Lan Y; Jin C
Microvasc Res; 2023 Nov; 150():104586. PubMed ID: 37451332
[TBL] [Abstract][Full Text] [Related]
18. CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB.
Roohipoor R; Sharifian E; Ghassemi F; Riazi-Esfahani M; Karkhaneh R; Fard MA; Zarei M; Modjtahedi BS; Moghimi S
Retina; 2016 Oct; 36(10):1997-2005. PubMed ID: 27046456
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.
Obeid A; Su D; Patel SN; Uhr JH; Borkar D; Gao X; Fineman MS; Regillo CD; Maguire JI; Garg SJ; Hsu J
Ophthalmology; 2019 Mar; 126(3):407-413. PubMed ID: 30077614
[TBL] [Abstract][Full Text] [Related]
20. Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).
Tonello M; Costa RA; Almeida FP; Barbosa JC; Scott IU; Jorge R
Acta Ophthalmol; 2008 Jun; 86(4):385-9. PubMed ID: 17995982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
